Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Sisram Medical Ltd. ( (HK:1696) ) has issued an update.
Sisram Medical Ltd announced its annual results for the year ended December 31, 2024, reporting a revenue of US$349.1 million, a decrease of 2.8% from the previous year. Despite the revenue decline, the gross profit margin improved to 62.1%. The company’s profit for the year was US$28.8 million, down by 12.6%. Notably, the revenue from direct sales increased to 87% of total revenue. Regional performance varied, with significant growth in the Middle East and Africa, while North America faced challenges due to a high-interest rate environment. The board declared a final dividend of HK$0.126 per share.
More about Sisram Medical Ltd.
Sisram Medical Ltd, incorporated in Israel, operates in the medical industry, focusing on providing innovative medical solutions. The company is listed on the Hong Kong Stock Exchange and is known for its advanced medical devices and technologies, catering to a global market with a significant presence in regions like APAC, Europe, and the Middle East.
YTD Price Performance: 16.67%
Average Trading Volume: 752,240
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$2.07B
Learn more about 1696 stock on TipRanks’ Stock Analysis page.